Multicenter phase II trial of neoadjuvant chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma.
Phase of Trial: Phase II
Latest Information Update: 06 Jan 2012
At a glance
- Drugs Docetaxel (Primary) ; Nedaplatin (Primary)
- Indications Oropharyngeal cancer
- Focus Therapeutic Use
- 13 Jan 2010 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 04 Jun 2009 New trial record.